Tetra Bio-Pharma Inc. Stock Toronto S.E.
Equities
TBP
CA88166Y1007
Pharmaceuticals
Sales 2020 | - | Sales 2021 | - | Capitalization | 88.81M 121M |
---|---|---|---|---|---|
Net income 2020 | -26M -35.55M | Net income 2021 | -52M -71.11M | EV / Sales 2020 | - |
Net cash position 2020 | 501K 685K | Net cash position 2021 | 1.77M 2.43M | EV / Sales 2021 | - |
P/E ratio 2020 |
-1.86
x | P/E ratio 2021 |
-1.7
x | Employees | 33 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.01% |
Managers | Title | Age | Since |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 16-05-31 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 16-05-31 |
Catherine Auld
BRD | Director/Board Member | - | 21-05-27 |
H. Norton
CHM | Chairman | 63 | 20-09-16 |
1st Jan change | Capi. | |
---|---|---|
+37.15% | 6.12B | |
-16.04% | 4.44B | |
-11.16% | 3.14B | |
-1.40% | 3.03B | |
+0.12% | 2.57B | |
+38.69% | 1.87B | |
+1.11% | 1.63B | |
-10.34% | 1.62B | |
-12.97% | 1.53B |